Understanding the SARS-CoV-2 to Manage COVID-19
The entire scientific community have come together in the last eight months to understand the details of the novel SARS-CoV-2 virus that has caused the COVID-19 pandemic. We now have a fair idea of the main targets that should be looked into in depth to fight the virus. However, the data from different population groups on the different testing or treatment strategies is still largely lacking. Populations are diverse in terms of their genetics, nutritional status, microbiota, access to facilities, among many other factors. This article makes a case for looking into women-specific data on test results, response to disease management strategies, as well as mortality due to COVID-19, otherwise currently missing.
Keywordscoronavirus genome - COVID-19 testing - COVID-19 vaccines - disease management - sex differences
05 October 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Tyrrell DAJ, Myint SH. Coronaviruses. In: Baron S. ed Medical Microbiology. 4th ed. Texas, USA: University of Texas Medical Branch at Galveston; 1996
- 2 Coronavirus. WHO | Regional Office for Africa. Available at: https://www.afro.who.int/publications/coronavirus. Accessed August 3, 2020
- 3 Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223) 507-513
- 4 WHO. | What is a pandemic? WHO. Available at: http://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/. Accessed August 3, 2020
- 5 Sen S, Anand KB, Karade S, Gupta RM. Coronaviruses: origin and evolution. Med J Armed Forces India 2020; (e-pub ahead of print) DOI: 10.1016/j.mjafi.2020.04.008.
- 6 Shang J, Ye G, Shi K. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 2020; 581 (7807) 221-224
- 7 Hoffmann M, Kleine-Weber H, Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181 (02) 271-280.e8
- 8 Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020; 76: 14-20
- 9 Coronavirus. Available at: https://www.who.int/westernpacific/health-topics/coronavirus. Accessed August 3, 2020
- 10 Bernheim A, Mei X, Huang M. et al. Chest CT findings in Coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020; 295 (03) 200463
- 11 Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol 2020; (e-pub ahead of print) DOI: 10.3389/fimmu.2020.01446.
- 12 Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev 2012; 76 (01) 16-32
- 13 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229) 1054-1062
- 14 Jain VK, Iyengar K, Vaish A, Vaishya R. Differential mortality in COVID-19 patients from India and western countries. Diabetes Metab Syndr 2020; 14 (05) 1037-1041
- 15 Jin J-M, Bai P, He W. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020; (e-pub ahead of print) DOI: 10.3389/fpubh.2020.00152.
- 16 de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14 (08) 523-534
- 17 Roved J, Westerdahl H, Hasselquist D. Sex differences in immune responses: Hormonal effects, antagonistic selection, and evolutionary consequences. Horm Behav 2017; 88: 95-105
- 18 Blunting of Cardioprotective Actions of Estrogen in Female Rodent Heart Linked to Altered Expression of Cardiac Tissue Chymase and ACE2. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805468/. Accessed August 3, 2020
- 19 Bukowska A, Spiller L, Wolke C. et al. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood) 2017; 242 (14) 1412-1423
- 20 Kadel S, Kovats S. Sex hormones regulate innate immune cells and promote sex differences in respiratory virus infection. Front Immunol 2018; (e-pub ahead of print) DOI: 10.3389/fimmu.2018.01653.
- 21 Song H, Seddighzadeh B, Cooperberg MR, Huang FW. Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells. Eur Urol 2020; 78 (02) 296-298
- 22 Clinckemalie L, Spans L, Dubois V. et al. Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element. Mol Endocrinol 2013; 27 (12) 2028-2040
- 23 Lucas JM, Heinlein C, Kim T. et al. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discov 2014; 4 (11) 1310-1325
- 24 O’Driscoll DN, De Santi C, McKiernan PJ, McEneaney V, Molloy EJ, Greene CM. Expression of X-linked Toll-like receptor 4 signaling genes in female vs. male neonates. Pediatr Res 2017; 81 (05) 831-837
- 25 Devaux CA, Rolain J-M, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect 2020; 53 (03) 425-435
- 26 Lu Z, Carter AC, Chang HY. Mechanistic insights in X-chromosome inactivation. Philos Trans R Soc B Biol Sci 2017; 372 (1733) 20160356
- 27 van der Made CI, Simons A, Schuurs-Hoeijmakers J. et al. Presence of genetic variants among young men with severe COVID-19. JAMA 2020; (e-pub ahead of print) DOI: 10.1001/jama.2020.13719.
- 28 Joe W, Kumar A, Rajpal S, Mishra US, Subramanian SV. Equal risk, unequal burden? Gender differentials in COVID-19 mortality in India. J Glob Health Sci 2020; (e-pub ahead of print) DOI: 10.35500/jghs.2020.2.e17.
- 29 COVID-19 Mortality Rates by Age and Gender: Why Is the Disease Killing More Men than Women? Available at: https://rgare.com/knowledge-center/media/research/covid-19-mortality-rates-by-age-and-gender-why-is-the-disease-killing-more-men-than-women. Accessed August 3, 2020
- 30 ICNARC. Reports. Available at: https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports. Accessed August 3, 2020
- 31 CDC. Information for Laboratories about Coronavirus (COVID-19). Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/lab-biosafety-guidelines.html. Accessed August 3, 2020
- 32 Mourya DT, Sapkal G, Yadav PD, M. Belani SK, Shete A, Gupta N. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res 2020; 151 (2 & 3) 172-176
- 33 Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn 2020; 20 (05) 453-454
- 34 Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection — Challenges and implications. N Engl J Med 2020; (e-pub ahead of print) DOI: 10.1056/NEJMp2015897.
- 35 Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020 (e-pub ahead of print). doi:10.1093/cid/ciaa344
- 36 Li Y, Yao L, Li J. et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol 2020; 92 (07) 903-908
- 37 Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Available at: https://pubmed.ncbi.nlm.nih.gov/32159775/. Accessed August 4, 2020
- 38 Kiran U, Gokulan CG, Kuncha SK. et al. Improved and simplified diagnosis of Covid-19 using TE extraction from dry swabs. bioRxiv 2020; (e-pub ahead of print) DOI: 10.1101/2020.05.31.126342.
- 39 Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions. Available at: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions. Accessed August 4, 2020
- 40 Stadnytskyi V, Bax CE, Bax A, Anfinrud P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc Natl Acad Sci USA 2020; 117 (22) 11875-11877
- 41 Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci USA 2020; 117 (26) 14857-14863
- 42 Banu S, Jolly B, Mukherjee P. et al. A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates. bioRxiv 2020; (e-pub ahead of print) DOI: 10.1101/2020.05.31.126136.
- 43 Bhoyar RC, Jain A, Sehgal P. et al. High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing. bioRxiv 2020; DOI: 10.1101/2020.08.10.242677.
- 44 Maitra A, Raghav S, Dalal A. et al. PAN-INDIA 1000 SARS-CoV-2 RNA genome sequencing reveals important insights into the outbreak. bioRxiv 2020; DOI: 10.1101/2020.08.03.233718.
- 45 Zhang X, Tan Y, Ling Y. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 2020; 583 (7816) 437-440
- 46 Messner CB, Demichev V, Wendisch D. et al. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection. Cell Syst 2020; 11 (01) 11-24.e4
- 47 Advisory on Use of Rapid Antigen Detection Test for COVID-19. https://www.icmr.gov.in/pdf/covid/strategy/Advisory_for_rapid_antigen_test14062020.pdf. Accessed August 3, 2020
- 48 Bhatnagar S. Comparative evaluation of SARS-CoV-2 IgG assays in India. medRxiv 2020. doi:10.1101/2020.08.12.20173856
- 49 Malani A, Shah D, Kang G, et al. Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020. Epidemiology; 2020. doi:10.1101/2020.08.27.20182741
- 50 SARS-CoV-2 RNA concentrations in primary municipal sewage sludge as a leading indicator of COVID-19 outbreak dynamics. medRxiv 2020. Available at: https://www.medrxiv.org/content/10.1101/2020.05.19.20105999v2. Accessed August 17, 2020
- 51 Corum J, Grady D, Wee S-L, Zimmer C. Coronavirus Vaccine Tracker. The New York Times. Available at: https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html. Accessed August 3, 2020
- 52 Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol 2019; 41 (02) 239-249
- 53 Verma S, Dhanak M, Frankenfield J. Visualizing the effectiveness of face masks in obstructing respiratory jets. Phys Fluids (1994) 2020; 32 (06) 061708
- 54 Dowd JB, Andriano L, Brazel DM. et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proc Natl Acad Sci USA 2020; 117 (18) 9696-9698
- 55 Nepomuceno MR, Acosta E, Alburez-Gutierrez D, Aburto JM, Gagnon A, Turra CM. Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden. Proc Natl Acad Sci USA 2020; 117 (25) 13881-13883